New Gene Therapy Company, Spark Therapeutics, Launches

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Posted By Irv Arons On November 15, 2013 @ 11:28 am In Industry News,NeuroOphthalmology,New Technologies,Research,Retina | Comments Disabled

Children’s Hospital of Philadelphia has spun out a new gene therapy company, Spark Therapeutics, that has taken over CHOP’s gene therapy programs. The new company takes over the advanced clinical trial for treating Leber’s Congenital Amaurosis, as well as an earlier stage trial for treating hemophilia B.

The Phase III clinical trial for Leber’s, is expected to be completed in mid-2015, and could become the first FDA-approved gene therapy treatment in the U.S.

To read more, please follow this link ^[1].

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/007127-new-gene-therapy-company-spark-therapeutics-launches/

URLs in this post:

[1] link: http://tinyurl.com/GeneTherapy21

Click here to print.